Accessibility Statement Skip Navigation
  • Resources
  • Blog
  • Journalists
  • +44 (0)20 7454 5110
  • Client Login
  • Send a Release
Return to PR Newswire homepage
  • News
  • Products
  • Contact
When typing in this field, a list of search results will appear and be automatically updated as you type.

Searching for your content...

No results found. Please change your search terms and try again.
  • News in Focus
      • Browse News Releases

      • All Public Company News
      • All Multimedia News
      • View All News Releases

      • Regulatory News

      • D/A/CH Regulatory News
      • UK Regulatory News
      • View All Regulatory News

  • Business & Money
      • Auto & Transportation

      • Aerospace & Defense
      • Air Freight
      • Airlines & Aviation
      • Automotive
      • Maritime & Shipbuilding
      • Railroads & Intermodal Transportation
      • Supply Chain/Logistics
      • Transportation, Trucking & Railroad
      • Travel
      • Trucking & Road Transportation
      • View All Auto & Transportation

      • Business Technology

      • Blockchain
      • Broadcast Tech
      • Computer & Electronics
      • Computer Hardware
      • Computer Software
      • Data Analytics
      • Electronic Commerce
      • Electronic Components
      • Electronic Design Automation
      • Financial Technology
      • High Tech Security
      • Internet Technology
      • Nanotechnology
      • Networks
      • Peripherals
      • Semiconductors
      • View All Business Technology

      • Entertain­ment & Media

      • Advertising
      • Art
      • Books
      • Entertainment
      • Film & Motion Picture
      • Magazines
      • Music
      • Publishing & Information Services
      • Radio & Podcast
      • Television
      • View All Entertain­ment & Media

      • Financial Services & Investing

      • Accounting News & Issues
      • Acquisitions, Mergers & Takeovers
      • Banking & Financial Services
      • Bankruptcy
      • Bond & Stock Ratings
      • Conference Call Announcements
      • Contracts
      • Cryptocurrency
      • Dividends
      • Earnings
      • Earnings Forecasts & Projections
      • Financing Agreements
      • Insurance
      • Investments Opinions
      • Joint Ventures
      • Mutual Funds
      • Private Placement
      • Real Estate
      • Restructuring & Recapitalisation
      • Sales Reports
      • Shareholder Activism
      • Shareholder Meetings
      • Stock Offering
      • Stock Split
      • Venture Capital
      • View All Financial Services & Investing

      • General Business

      • Awards
      • Commercial Real Estate
      • Corporate Expansion
      • Earnings
      • Environmental, Social and Governance (ESG)
      • Human Resource & Workforce Management
      • Licensing
      • New Products & Services
      • Obituaries
      • Outsourcing Businesses
      • Overseas Real Estate (non-US)
      • Personnel Announcements
      • Real Estate Transactions
      • Residential Real Estate
      • Small Business Services
      • Socially Responsible Investing
      • Surveys, Polls & Research
      • Trade Show News
      • View All General Business

  • Science & Tech
      • Consumer Technology

      • Artificial Intelligence
      • Blockchain
      • Cloud Computing/Internet of Things
      • Computer Electronics
      • Computer Hardware
      • Computer Software
      • Consumer Electronics
      • Cryptocurrency
      • Data Analytics
      • Electronic Commerce
      • Electronic Gaming
      • Financial Technology
      • Mobile Entertainment
      • Multimedia & Internet
      • Peripherals
      • Social Media
      • STEM (Science, Tech, Engineering, Math)
      • Supply Chain/Logistics
      • Wireless Communications
      • View All Consumer Technology

      • Energy & Natural Resources

      • Alternative Energies
      • Chemical
      • Electrical Utilities
      • Gas
      • General Manufacturing
      • Mining
      • Mining & Metals
      • Oil & Energy
      • Oil & Gas Discoveries
      • Utilities
      • Water Utilities
      • View All Energy & Natural Resources

      • Environ­ment

      • Conservation & Recycling
      • Environmental Issues
      • Environmental Policy
      • Environmental Products & Services
      • Green Technology
      • Natural Disasters
      • View All Environ­ment

      • Heavy Industry & Manufacturing

      • Aerospace & Defence
      • Agriculture
      • Chemical
      • Construction & Building
      • General Manufacturing
      • HVAC (Heating, Ventilation & Air-Conditioning)
      • Machinery
      • Machine Tools, Metalworking & Metallurgy
      • Mining
      • Mining & Metals
      • Paper, Forest Products & Containers
      • Precious Metals
      • Textiles
      • Tobacco
      • View All Heavy Industry & Manufacturing

      • Telecomm­unications

      • Carriers & Services
      • Mobile Entertainment
      • Networks
      • Peripherals
      • Telecommunications Equipment
      • Telecommunications Industry
      • VoIP (Voice over Internet Protocol)
      • Wireless Communications
      • View All Telecomm­unications

  • Lifestyle & Health
      • Consumer Products & Retail

      • Animals & Pets
      • Beers, Wines & Spirits
      • Beverages
      • Bridal Services
      • Cannabis
      • Cosmetics & Personal Care
      • Fashion
      • Food & Beverages
      • Furniture & Furnishings
      • Home Improvement
      • Household, Consumer & Cosmetics
      • Household Products
      • Jewellery
      • Non-Alcoholic Beverages
      • Office Products
      • Organic Food
      • Product Recalls
      • Restaurants
      • Retail
      • Supermarkets
      • Toys
      • View All Consumer Products & Retail

      • Entertain­ment & Media

      • Advertising
      • Art
      • Books
      • Entertainment
      • Film & Motion Picture
      • Magazines
      • Music
      • Publishing & Information Services
      • Radio & Podcast
      • Television
      • View All Entertain­ment & Media

      • Health

      • Biometrics
      • Biotechnology
      • Clinical Trials & Medical Discoveries
      • Dentistry
      • FDA Approval
      • Fitness/Wellness
      • Health Care & Hospitals
      • Health Insurance
      • Infection Control
      • International Medical Approval
      • Medical Equipment
      • Medical Pharmaceuticals
      • Mental Health
      • Pharmaceuticals
      • Supplementary Medicine
      • View All Health

      • Sports

      • General Sports
      • Outdoors, Camping & Hiking
      • Sporting Events
      • Sports Equipment & Accessories
      • View All Sports

      • Travel

      • Amusement Parks & Tourist Attractions
      • Gambling & Casinos
      • Hotels & Resorts
      • Leisure & Tourism
      • Outdoors, Camping & Hiking
      • Passenger Aviation
      • Travel Industry
      • View All Travel

  • Policy & Public Interest
      • Policy & Public Interest

      • Animal Welfare
      • Corporate Social Responsibility
      • Economic News, Trends & Analysis
      • Education
      • Environmental
      • European Government
      • Labour & Union
      • Natural Disasters
      • Not For Profit
      • Public Safety
      • View All Policy & Public Interest

  • People & Culture
      • People & Culture

      • Aboriginal, First Nations & Native American
      • African American
      • Asian American
      • Children
      • Diversity, Equity & Inclusion
      • Hispanic
      • Lesbian, Gay & Bisexual
      • Men's Interest
      • People with Disabilities
      • Religion
      • Senior Citizens
      • Veterans
      • Women
      • View All People & Culture

  • Overview
  • Distribution
  • Paid Placement
  • Multichannel Amplification
  • Disclosure Services
  • SocialBoost
  • Rooms
    • MediaRoom
    • ESG Rooms
  • AI Tools
  • General Enquiries
  • Media Enquiries
  • Partnerships
  • Hamburger menu
  • Cision PR Newswire UK provides press release distribution, targeting, monitoring, and marketing services
  • Send a Release
    • Phone

    • +44 (0)20 7454 5110 from 8 AM - 5:30 PM GMT

    • ALL CONTACT INFO
    • Contact Us

      +44 (0)20 7454 5110
      from 8 AM - 5:30 PM GMT

  • Client Login
  • Send a Release
  • Resources
  • Blog
  • Journalists
  • News in Focus
    • Browse News Releases
    • Regulatory News
  • Business & Money
    • Auto & Transportation
    • Business Technology
    • Entertain­ment & Media
    • Financial Services & Investing
    • General Business
  • Science & Tech
    • Consumer Technology
    • Energy & Natural Resources
    • Environ­ment
    • Heavy Industry & Manufacturing
    • Telecomm­unications
  • Lifestyle & Health
    • Consumer Products & Retail
    • Entertain­ment & Media
    • Health
    • Sports
    • Travel
  • Policy & Public Interest
    • Policy & Public Interest
  • People & Culture
    • People & Culture
  • Client Login
  • Send a Release
  • Resources
  • Blog
  • Journalists
  • Overview
  • Distribution
  • Paid Placement
  • Multichannel Amplification
  • Disclosure Services
  • Cision Communications Cloud®
  • AI Tools
  • Client Login
  • Send a Release
  • Resources
  • Blog
  • Journalists
  • General Enquiries
  • Media Enquiries
  • Partnerships
  • Client Login
  • Send a Release
  • Resources
  • Blog
  • Journalists

The Working Life of Over a Quarter of Employees With Rheumatoid Arthritis is Affected due to Joint Morning Stiffness


News provided by

Mundipharma International Limited

11 Oct, 2011, 23:01 GMT

Share this article

Share toX

Share this article

Share toX

LONDON, October 12, 2011 /PRNewswire/ --

RA patients agree better management of joint morning stiffness caused by rheumatoid arthritis would help get them back to work

On World Arthritis Day, new research from Mundipharma International Limited reveals that across Europe, 28% of those with RA who are employed and suffered from morning stiffness for at least one hour per day (n=582) have reduced the number of hours they work and 29% have been unable to work as a direct result of morning joint stiffness caused by RA.[1]

In addition, almost half (47%, n=534) of those with RA who are in employment and who suffer from morning stiffness for at least an hour each morning believe their performance at work is adversely affected by their morning stiffness.[1] Patients whose work is affected by their symptoms state this happens, on average, for a cumulative 8.7 hours each week.[1] During these hours patients believe they are only performing at 59% of their usual level.[1]

These findings form part of research commissioned by Mundipharma International to understand the impact of RA and its associated symptoms on working life. The views of 1,061 RA patients of working age across Europe were analysed. Those surveyed had been diagnosed with RA for six months or more and all suffered from morning stiffness of the joints at least three times a week.[1]

Two of the most distressing symptoms people with RA experience are joint stiffness and pain which can become more pronounced in the mornings. The complexity of these morning symptoms - which can also include physical dysfunction - can result in difficulties carrying out tasks early in the day[2,3]. The survey found that four in ten people with RA (44% N=1061) agreed that a reduction in joint stiffness for just 30 minutes each morning would significantly improve their quality of life which could potentially help them overcome morning obstacles that impact on working life.[1]

Risto Tuominen, health economist and Professor of Healthcare, University of Turku, Finland, commented on the research: "In my experience, people who are unable to work as a result of their RA-related morning stiffness want to get back into the workplace. It is therefore our duty, as healthcare professionals, to support these patients to ensure their morning joint function problems are better managed so that they are in a position to return to work and function at a productive level."

Lateness is also an issue for those with morning stiffness of the joints. A third (33%, n=534) of those with RA surveyed say their joint morning stiffness causes them to arrive late at work, with each person accumulating an estimated 104 hours or 13 days of working time lateness annually. In terms of sick leave, over one in 10 (15%, n=534) of those with RA who are employed, took sick leave in the last month as a direct result of RA-related morning joint stiffness; this sick leave equated to an average 54 days of working time lost each year per respondent[1].

The research further revealed that not only is productivity, time at work and absenteeism affected but that morning stiffness also has an emotional toll on those working with RA. Of those surveyed who are working, and whose work is adversely affected by morning stiffness (n=250) , 33% experienced a lack of patience, lack of concentration (28%) and feelings of pressure (20%) as a result of RA-related morning joint stiffness.[1] One in 10 (11%) also cites difficulties with working relationships.[1]  

Frank Buttgereit, Professor of Rheumatology and Clinical Immunology, Charité University Medicine, Berlin, Germany, explained: "Joint stiffness due to RA in the morning is caused by increased inflammation, the result of a build up of pro-inflammatory chemicals in the body overnight. This RA-related morning stiffness impacts significantly on the lives of those living with the disease. Those suffering from morning stiffness can take up to three hours to get ready in the morning which in turn has an inevitable effect on the start of the working day in terms of punctuality, productivity and emotional wellbeing."

Rheumatoid arthritis (RA) is a chronic, progressive, inflammatory disease which causes damage to the cartilage and bone in the affected joints.[4] Mornings in particular are worse for people affected by RA. The stiffness and pain experienced can result in difficulties with mobility and carrying out every day morning tasks, significantly impacting the working lives of people affected by RA. It is estimated that about three million people in Europe have rheumatoid arthritis, many of whom are of working age.[5]

Notes to Editors:

About the research

Interviews were conducted by telephone between April and July 2011. The survey was carried out across 1,061 patients of working age from Germany, Italy, Belgium, Sweden, Denmark, Finland, France, Norway, UK, Poland and Spain. 'Working age' was defined as those aged 18+. The upper age limit was determined by the retirement age in each country. All patients surveyed had been diagnosed with RA for at least six months and all suffered from stiffness in the joints first thing in the morning at least three days a week.

About the calculations

The following statement: "this sick leave equated to an average 54 days of working time lost each year per respondent" was determined by the following calculation:

Sick leave: Average number of sick days per month because of morning stiffness = 4.5 days. 4.5 days x 12 (number of months in a year) = 54 (number of sick days off per year).  

The following statement: "In addition, a third (33%, n=534) of those with RA surveyed say their joint morning stiffness causes them to arrive late at work, with each person  accumulating an estimated 104 hours or 13 days of working time  lateness annually" was determined by the following calculation:

Lateness: Average number of hours late per 5 day working week because of morning stiffness = 2.3 hours. 2.3 hours / 5 days = 0.46 hours (number of hours late per day). 0.46 hours x 226 (number of working days in the year) = 103.96 hours (number of hours late a year). 103.96 / 7.9[6] (average European working hours per day) = 13.2 days (number of working days late per year)

About Mundipharma International Limited

The Mundipharma/Napp/Norpharma independent associated companies are privately owned companies and joint ventures covering the world's pharmaceutical markets. The companies worldwide are dedicated to bringing to patients with severe and debilitating diseases the benefits of novel treatment options in fields such as severe pain, haemato-oncology and respiratory disease. For more information: http://www.mundipharma.co.uk/

References

1. Ipsos MORI Rheumatoid Arthritis patient survey: Impact of MS on work life. July 2011. Participants: 1,172 RA patients of working age

2. Buttgereit F, Doering G, Schaeffler A et al. Efficacy of modified-release versus standard prednisone to reduce duration of morning stiffness of the joints in rheumatoid arthritis (CAPRA-1): a double-blind, randomised controlled trial. Lancet 2008; 371: 205-214

3.Westhoff G, Buttgereit F, Gromnica-Ihle E et al. Morning stiffness and its influence on early retirement in patients with recent onset rheumatoid arthritis. Rheumatology 2008; 47(7): 980-984

4.Goldring S.R. Pathogenesis of bone and cartilage destruction in rheumatoid arthritis. Rheumatology 2003; 42 (Suppl 2); ii11 - ii16

5.Lundkvist J, Kastäng F, Kobelt G. The burden of rheumatoid arthritis and access to treatment: health burden and costs. Eur J Health Econ 2008; 8 (Suppl 2): S49-60

6.European Foundation for the Improvement of Living and Working Conditions. Working time developments - 2009. July 2010. 
 

Modal title

Contact PR Newswire

  • +44 (0)20 7454 5110
    from 8 AM - 5:30 PM GMT
  • General Enquiries
  • Media Enquiries
  • Partnerships

Products

  • Content Distribution
  • Multimedia Services
  • Disclosure Services
  • Cision Communications Cloud®

About

  • About PR Newswire
  • About Cision
  • Partnering Opportunities
  • Careers
  • Accessibility Statement
  • APAC
  • APAC - Simplified Chinese
  • APAC - Traditional Chinese
  • Brazil
  • Canada
  • Czech
  • Denmark
  • Finland
  • France
  • Germany
  • India
  • Indonesia
  • Israel
  • Japan
  • Korea
  • Mexico
  • Middle East
  • Middle East - Arabic
  • Netherlands
  • Norway
  • Poland
  • Portugal
  • Russia
  • Slovakia
  • Spain
  • Sweden
  • United States
  • Vietnam

My Services

  • All News Releases
  • Customer Portal
  • Resources
  • Blog
  • Journalists
  • Data Privacy

Do not sell or share my personal information:

  • Submit via Privacy@cision.com 
  • Call Privacy toll-free: 877-297-8921

Contact PR Newswire

Products

About

My Services
  • All News Releases
  • Customer Portal
  • Resources
  • Blog
  • Journalists
+44 (0)20 7454 5110
from 8 AM - 5:30 PM GMT
  • Terms of Use
  • Privacy Policy
  • Information Security Policy
  • Site Map
  • RSS
  • Cookie Settings
Copyright © 2025 PR Newswire Europe Limited. All Rights Reserved. A Cision company.